SCHEMBL17716986

SCHEMBL17716986

COc1cccc2cc(-c3nnc(NC(=O)c4ccc(S(=O)(=O)N(C)C)cc4)o3)oc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 9/20 0.69
▸ TDP1 Q9NUW8 9/20 0.69
▸ KDM4E B2RXH2 8/20 0.69
▸ TP53 P04637 7/20 0.69
▸ ALOX15 P16050 4/20 0.69
▸ MEN1 O00255 11/20 0.56
▸ KMT2A Q03164 11/20 0.56
▸ SMN1; SMN2 Q16637 10/20 0.56
▸ HTT P42858 8/20 0.56
▸ HPGD P15428 2/20 0.56
▸ L3MBTL1 Q9Y468 2/20 0.56
▸ RAB9A P51151 2/20 0.53
▸ MAPT P10636 1/20 0.53
▸ ALDH1A1 P00352 3/20 0.52
▸ USP2 O75604 3/20 0.51
▸ CRHBP P24387 1/20 0.51
▸ CRHR2 Q13324 1/20 0.51
▸ ADCY8 P40145 1/20 0.49
▸ ADCY1 Q08828 1/20 0.49
▸ GAA P10253 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17716987 0.81 KDM4E (0.62) LMNATDP1KDM4EMEN1KMT2A
SCHEMBL17717044 0.77 RAB9A (0.72) LMNATDP1KDM4EMEN1KMT2A
SCHEMBL17717072 0.76 KDM4E (0.61) LMNATDP1KDM4EALOX15MEN1
SCHEMBL17716978 0.74 KDM4E (0.84) LMNATDP1KDM4ETP53ALOX15
SCHEMBL21478128 0.74 LMNA (0.79) LMNATDP1KDM4ETP53ALOX15
SCHEMBL17718569 0.72 SMN1; SMN2 (0.69) LMNATDP1KDM4ETP53ALOX15
SCHEMBL17717121 0.72 F10 (0.51) LMNATDP1TP53MEN1KMT2A
SCHEMBL21478145 0.72 KDM4E (0.72) LMNATDP1KDM4ETP53ALOX15
SCHEMBL17716938 0.71 LMNA (0.75) LMNATDP1KDM4ETP53ALOX15
SCHEMBL13571199 0.71 KDM4E (0.79) LMNATDP1KDM4ETP53ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170273954-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS THE UNIVERSITY OF CHICAGO (US) 2017-09-28 — — US disclosed
US-20170273954-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS THE UNIVERSITY OF CHICAGO (US) 2017-09-28 — — US disclosed
US-9675592-B2 Methods and compositions for bacteria infections THE UNIVERSITY OF CHICAGO (US) 2017-06-13 — — US disclosed
US-9675592-B2 Methods and compositions for bacteria infections THE UNIVERSITY OF CHICAGO (US) 2017-06-13 — — US disclosed
US-20160120852-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS THE BOARD OF REGENTS OF THE UNIVERSITY OF ILLINOIS (US) 2016-05-05 — — US disclosed
US-20160120852-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS THE BOARD OF REGENTS OF THE UNIVERSITY OF ILLINOIS (US) 2016-05-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170273954-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS SPOUT1, OXA1L, VSIR LMNA 1893/4885TDP1 3980/4885KDM4E 916/4885
US-20160120852-A1 METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS SPOUT1, OXA1L, VSIR LMNA 1893/4885TDP1 3980/4885KDM4E 916/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback